Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosine kinase overexpressed in more that 60 % of human breast carcinomas. The overexpression of BRK has been shown to sensitize mammary epithelial cells to mitogenic signaling and to promote cell proliferation and tumor formation. The molecular mechanisms of BRK have been unveiled by the identification and characterization of BRK target proteins. Downstream of tyrosine kinases 1 or Dok1 is a scaffolding protein and a substrate of several tyrosine kinases. Herein we show that BRK interacts with and phosphorylates Dok1 specifically on Y362. We demonstrate that this phosphorylation by BRK significantly downregulates Dok1 in a ubiquitin-proteasome-med...
© 2009 American Society for Investigative Pathology. The full and final published article is availab...
Brk, a tyrosine kinase expressed in a majority of breast tumors, but not normal mammary tissue, prom...
Tyrosine kinases orchestrate key cellular signaling pathways and their dysregulation is often associ...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
Epidermal growth factor receptor (EGFR)-mediated cell signaling is critical for mammary epithelial c...
Brk (for breast tumor kinase) is a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kin...
Cellular transformation induced by oncogenic tyrosine kinases is a multi-step process involving acti...
<div><p>Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emer...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emerging as ...
<p>(A) Cellular proteins were detected in total cell lysates by immunoblotting analysis with anti-Do...
Breast tumor kinase (Brk), an Src-like nonreceptor tyrosine kinase, is overexpressed in breast cance...
PTK6, also known as Brk, is highly expressed in over 80% of breast cancers. In the last decade sever...
Brk (breast tumor kinase, also known as PTK6) is a nonreceptor tyrosine kinase that is aberrantly ex...
© 2009 American Society for Investigative Pathology. The full and final published article is availab...
Brk, a tyrosine kinase expressed in a majority of breast tumors, but not normal mammary tissue, prom...
Tyrosine kinases orchestrate key cellular signaling pathways and their dysregulation is often associ...
Breast tumor kinase (BRK), also known as protein tyrosine kinase 6 (PTK6), is a non-receptor tyrosin...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
Epidermal growth factor receptor (EGFR)-mediated cell signaling is critical for mammary epithelial c...
Brk (for breast tumor kinase) is a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kin...
Cellular transformation induced by oncogenic tyrosine kinases is a multi-step process involving acti...
<div><p>Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emer...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emerging as ...
<p>(A) Cellular proteins were detected in total cell lysates by immunoblotting analysis with anti-Do...
Breast tumor kinase (Brk), an Src-like nonreceptor tyrosine kinase, is overexpressed in breast cance...
PTK6, also known as Brk, is highly expressed in over 80% of breast cancers. In the last decade sever...
Brk (breast tumor kinase, also known as PTK6) is a nonreceptor tyrosine kinase that is aberrantly ex...
© 2009 American Society for Investigative Pathology. The full and final published article is availab...
Brk, a tyrosine kinase expressed in a majority of breast tumors, but not normal mammary tissue, prom...
Tyrosine kinases orchestrate key cellular signaling pathways and their dysregulation is often associ...